DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Tanaka Y, Martin Mola E.
IL-6 targeting compared to TNF targeting in rheumatoid arthritis: studies of olokizumab, sarilumab and sirukumab.
Ann Rheum Dis 2014;
73: 1595-1597
We do not assume any responsibility for the contents of the web pages of other providers.